作者: Alexander Gerhard , Iris Trender-Gerhard , Federico Turkheimer , Niall P. Quinn , Kailash P. Bhatia
DOI: 10.1002/MDS.20668
关键词: Basal ganglia 、 Pathology 、 Corticobasal degeneration 、 Brainstem 、 Cerebellum 、 Progressive supranuclear palsy 、 Neuroglia 、 Medicine 、 Parkinsonism 、 Frontal lobe
摘要: Progressive supranuclear palsy (PSP) is a neurodegenerative disease presenting with voluntary gaze difficulties, early falls, and Parkinsonism. Neuronal loss, associated intracellular neurofibrillary tangles activated microglia, found targeting the basal ganglia, brainstem nuclei, frontal cortex. [(11)C](R)-PK11195 PET marker of peripheral benzodiazepine binding sites (PBBS) expressed by microglia. We have used to demonstrate in vivo degree distribution glial response degenerative process four patients PSP. Compared normal age-matched controls, PSP patient group showed significantly increased mean midbrain, lobe, cerebellum. Two were rescanned after 6 10 months during that time level microglial activation remained stable. reveals pattern involving cortical subcortical regions corresponds well known neuropathological changes. PET, therefore, may help characterizing underlying activity (c) 2005 Movement Disorder Society.